# 60505-4743-1 · Lisdexamfetamine Dimesylate Capsule · Apotex Corp. — FDA drug shortage duration tracker

For 60505-4743-1 · Lisdexamfetamine Dimesylate Capsule · Apotex Corp., package ndc is 60505-4743-1; generic name is Lisdexamfetamine Dimesylate Capsule; manufacturer is Apotex Corp; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

- **Package NDC:** 60505-4743-1 _(verified: appears in the quote below)_
- **Generic name:** Lisdexamfetamine Dimesylate Capsule _(verified: appears in the quote below)_
- **Manufacturer:** Apotex Corp. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated recovery: Week of 8/24/26 _(verified: appears in the quote below)_
- **Initial posting date:** 11/01/2023 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1035 _(our reading, not quoted from the source)_
- **Reason for shortage:** Delay in shipping of the drug _(verified: appears in its own passage below)_
- **Dosage form:** Capsule _(verified: appears in its own passage below)_
- **Therapeutic category:** Psychiatry _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "11/01/2023", "package_ndc": "60505-4743-1", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-706-5575", "availability": "Unavailable", "related_info": "Estimated recovery: Week of 8/24/26"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

### Status

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

### Last update date

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

### Reason for shortage

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

### Dosage form

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

### Therapeutic category

> "update_date": "08/24/2026", "therapeutic_category": [ "Psychiatry" ], "dosage_form": "Capsule", "presentation": "Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)", "company_name": "Apotex Corp.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

## The same source also states

> "initial_posting_date": "11/01/2023", "package_ndc": "60505-4743-1", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-706-5575", "availability": "Available"

Source: https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).